ATE291434T1 - Verwendung von angiotensin zur behandlung von krebsmetastasierung - Google Patents

Verwendung von angiotensin zur behandlung von krebsmetastasierung

Info

Publication number
ATE291434T1
ATE291434T1 AT99940353T AT99940353T ATE291434T1 AT E291434 T1 ATE291434 T1 AT E291434T1 AT 99940353 T AT99940353 T AT 99940353T AT 99940353 T AT99940353 T AT 99940353T AT E291434 T1 ATE291434 T1 AT E291434T1
Authority
AT
Austria
Prior art keywords
angiotensin
treat cancer
cancer metastasis
treatment
cancer
Prior art date
Application number
AT99940353T
Other languages
English (en)
Inventor
Gavin Paul Vinson
John Richard Puddefoot
Miles Gordon Berry
Original Assignee
Queen Mary & Westfield College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9818023.5A external-priority patent/GB9818023D0/en
Priority claimed from GBGB9820000.9A external-priority patent/GB9820000D0/en
Application filed by Queen Mary & Westfield College filed Critical Queen Mary & Westfield College
Application granted granted Critical
Publication of ATE291434T1 publication Critical patent/ATE291434T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT99940353T 1998-08-18 1999-08-18 Verwendung von angiotensin zur behandlung von krebsmetastasierung ATE291434T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9818023.5A GB9818023D0 (en) 1998-08-18 1998-08-18 Cancer treatment
GBGB9820000.9A GB9820000D0 (en) 1998-09-14 1998-09-14 Cancer treatment
PCT/GB1999/002727 WO2000010590A2 (en) 1998-08-18 1999-08-18 Cancer treatment

Publications (1)

Publication Number Publication Date
ATE291434T1 true ATE291434T1 (de) 2005-04-15

Family

ID=26314231

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99940353T ATE291434T1 (de) 1998-08-18 1999-08-18 Verwendung von angiotensin zur behandlung von krebsmetastasierung

Country Status (7)

Country Link
US (1) US6852316B2 (de)
EP (1) EP1104305B1 (de)
AT (1) ATE291434T1 (de)
AU (1) AU5434899A (de)
DE (1) DE69924385T2 (de)
ES (1) ES2239454T3 (de)
WO (1) WO2000010590A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236761B2 (en) * 2006-07-07 2012-08-07 Washington State University Research Foundation C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
WO2008005531A2 (en) * 2006-07-07 2008-01-10 Washington State University Research Foundation C-met receptor regulation by angiotensin iv (at4) receptor ligands
US20090042296A1 (en) * 2007-03-16 2009-02-12 Marie Callahan Transfection ready eukaryotic cells
US8378100B2 (en) * 2008-01-09 2013-02-19 University Of Virginia Patent Foundation Phosphonate derivatives as autotaxin inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034627A2 (en) * 1996-03-19 1997-09-25 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. Protection of hemopoietic cells during chemotherapy or radiotherapy

Also Published As

Publication number Publication date
EP1104305A2 (de) 2001-06-06
EP1104305B1 (de) 2005-03-23
DE69924385D1 (de) 2005-04-28
DE69924385T2 (de) 2006-01-19
AU5434899A (en) 2000-03-14
US20020119142A1 (en) 2002-08-29
US6852316B2 (en) 2005-02-08
WO2000010590A3 (en) 2000-05-18
ES2239454T3 (es) 2005-09-16
WO2000010590A2 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE60142590D1 (de) Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE324908T1 (de) Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems
ATE411016T1 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE69825286D1 (de) Verwendung von cholinesterasehemmern zur behandlung von aufmerksamkeitsmangel-störungen
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE332688T1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
EP1056458A4 (de) Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
ATE246924T1 (de) Neue therapeutische verwendung von nicergoline
DE60128084D1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
ATE354361T1 (de) Neue verwendung von prodigiosin zur behandlung von diabetes mellitus
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
NO984198L (no) FremgangsmÕte for behandling av aggresjon
ATE486594T1 (de) Methode zur behandlung von herzinsuffizienz
DE59904564D1 (de) Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties